XenTech
Preclinical oncology drug evaluation
- B2B
About XenTech
Biotech/CRO offering preclinical services for oncology drug evaluation (PDX, CDX). It also develops R&D programs to correlate drug response with molecular features.
Key facts
- Industry
- Biotechnology
- Company size
- 11–50 employees
- Headquarters
- Évry-Courcouronnes, Île-de-France, France
- Founded
- 2006
- Revenue
- $6.5M – $51.2MTamtam estimate
- Website
- xentech.eu
- linkedin.com/company/xentech
XenTech at a glance
XenTech is a B2B company in the Biotechnology industry, headquartered in Évry-Courcouronnes, Île-de-France, France.
XenTech was founded in 2006.
XenTech has 11–50 employees.
XenTech's revenue is $6.5M – $51.2M (Tamtam estimate).
Selling to companies like XenTech?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies